Loading clinical trials...
Loading clinical trials...
Association of FC Gamma RIIIA Polymorphism and Thrombopoietin (THPO) Expression With Response to TPO Agonists in Refractory ITP and the Impact of Therapy on B and T Cells Subsets in the Patients With Mutated Genotypes
Conditions
Interventions
Eltrombopag
Locations
1
Pakistan
Armed Forces Bone Marrow Transplant Centre
Rawalpindi, Punjab Province, Pakistan
Start Date
July 1, 2016
Primary Completion Date
July 1, 2017
Completion Date
September 1, 2017
Last Updated
August 24, 2016
NCT06722235
NCT03866577
NCT00162006
Lead Sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions